Patents by Inventor Kanta Subbarao

Kanta Subbarao has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for inducing an immune response and formulations thereof
    Patent number: 10179174
    Abstract: The invention is related to peptide constructs, i.e., polypeptides obtained by linking together two or more peptides based on or derived from different molecules, which are useful in the treatment or prevention of influenza virus and other infectious diseases. Compositions containing the same, methods for producing the same, and methods for using the same are also disclosed, wherein the peptide constructs have the formula P1-x-P2, where P2 is a peptide associated with an infectious agent and P1 is a peptide that will bind to a class of immune cells, such as dendritic cells. The peptide construct can cause the maturation of immature dendritic cells to a more mature state. The peptide construct or the more mature dendritic cell can be administered to a subject to modulate or initiate an immune response against an infectious agent.
    Type: Grant
    Filed: May 24, 2012
    Date of Patent: January 15, 2019
    Assignee: Cel-Sci Corp.
    Inventors: Daniel H. Zimmerman, Eyal Talor, Kanta Subbarao, Kobporn Boonnak
  • Influenza hemagglutinin and neuraminidase variants
    Patent number: 9119812
    Abstract: Polypeptides, polynucleotides, reassortant viruses, immunogenic compositions and vaccines comprising influenza hemagglutinin and neuraminidase variants and method using thereof are provided.
    Type: Grant
    Filed: November 21, 2013
    Date of Patent: September 1, 2015
    Assignee: MedImmune, LLC
    Inventors: Hong Jin, Xing Cheng, Kanta Subbarao
  • METHOD FOR INDUCING AN IMMUNE RESPONSE AND FORMULATIONS THEREOF
    Publication number: 20150140065
    Abstract: The invention is related to peptide constructs, i.e., polypeptides obtained by linking together two or more peptides based on or derived from different molecules, which are useful in the treatment or prevention of influenza virus and other infectious diseases. Compositions containing the same, methods for producing the same, and methods for using the same are also disclosed, wherein the peptide constructs have the formula P1-x-P2, where P2 is a peptide associated with an infectious agent and P1 is a peptide that will bind to a class of immune cells, such as dendritic cells. The peptide construct can cause the maturation of immature dendritic cells to a more mature state. The peptide construct or the more mature dendritic cell can be administered to a subject to modulate or initiate an immune response against an infectious agent.
    Type: Application
    Filed: May 24, 2012
    Publication date: May 21, 2015
    Applicant: CEL-SCI CORPORATION
    Inventors: Daniel H. Zimmerman, Eyal Talor, Kanta Subbarao, Kobporn Boonnak
  • Influenza hemagglutinin and neuraminidase variants
    Patent number: 8765136
    Abstract: Polypeptides, polynucleotides, methods, compositions, and vaccines comprising (avian pandemic) influenza hemagglutinin and neuraminidase variants are provided.
    Type: Grant
    Filed: April 28, 2010
    Date of Patent: July 1, 2014
    Assignee: MedImmune, LLC
    Inventors: Chin-Fen Yang, George Kemble, Kanta Subbarao, Brian Murphy
  • INFLUENZA HEMAGGLUTININ AND NEURAMINIDASE VARIANTS
    Publication number: 20140079726
    Abstract: Polypeptides, polynucleotides, reassortant viruses, immunogenic compositions and vaccines comprising influenza hemagglutinin and neuraminidase variants and method using thereof are provided.
    Type: Application
    Filed: November 21, 2013
    Publication date: March 20, 2014
    Applicant: MEDIMMUNE, LLC
    Inventors: Hong JIN, Xing CHENG, Kanta SUBBARAO
  • Influenza hemagglutinin and neuraminidase variants
    Patent number: 8613935
    Abstract: Polypeptides, polynucleotides, reassortant viruses, immunogenic compositions and vaccines comprising influenza hemagglutinin and neuraminidase variants and method using thereof are provided.
    Type: Grant
    Filed: February 3, 2010
    Date of Patent: December 24, 2013
    Assignee: Medimmune, LLC
    Inventors: Hong Jin, Xing Cheng, Kanta Subbarao
  • INFLUENZA HEMAGGLUTININ AND NEURAMINIDASE VARIANTS
    Publication number: 20110182936
    Abstract: Polypeptides, polynucleotides, methods, compositions, and vaccines comprising (avian pandemic) influenza hemagglutinin and neuraminidase variants are provided.
    Type: Application
    Filed: March 31, 2011
    Publication date: July 28, 2011
    Inventors: Chin-Fen Yang, George Kemble, Kanta Subbarao, Brian Murphy
  • INFLUENZA HEMAGGLUTININ AND NEURAMINIDASE VARIANTS
    Publication number: 20110052618
    Abstract: Polypeptides, polynucleotides, methods, compositions, and vaccines comprising (avian pandemic) influenza hemagglutinin and neuraminidase variants are provided.
    Type: Application
    Filed: April 28, 2010
    Publication date: March 3, 2011
    Applicants: MEDIMMUNE, LLC, GOVERNMENT OF THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT
    Inventors: Chin-Fen YANG, George KEMBLE, Kanta SUBBARAO, Brian MURPHY
  • INFLUENZA HEMAGGLUTININ AND NEURAMINIDASE VARIANTS
    Publication number: 20100330118
    Abstract: Polypeptides, polynucleotides, reassortant viruses, immunogenic compositions and vaccines comprising influenza hemagglutinin and neuraminidase variants and method using thereof are provided.
    Type: Application
    Filed: February 3, 2010
    Publication date: December 30, 2010
    Applicants: MEDIMMUNE, LLC, The Government of the United States of America, National Institutes of Health
    Inventors: Hong JIN, Xing CHENG, Kanta SUBBARAO
  • Influenza hemagglutinin and neuraminidase variants
    Patent number: 7744901
    Abstract: Polypeptides, polynucleotides, methods, compositions, and vaccines comprising (avian pandemic) influenza hemagglutinin and neuraminidase variants are provided.
    Type: Grant
    Filed: January 15, 2009
    Date of Patent: June 29, 2010
    Assignees: MedImmune, LLC, National Institute of Health
    Inventors: Chin-Fen Yang, George Kemble, Kanta Subbarao, Brian Murphy
  • Influenza Hemagglutinin and Neuraminidase Variants
    Publication number: 20090136530
    Abstract: Polypeptides, polynucleotides, methods, compositions, and vaccines comprising (avian pandemic) influenza hemagglutinin and neuraminidase variants are provided.
    Type: Application
    Filed: January 15, 2009
    Publication date: May 28, 2009
    Applicants: MedImmune, LLC, Government of The United States of America As Represented By the Secretary Of The Department Of
    Inventors: Chin-Fen Yang, George Kemble, Kanta Subbarao, Brian Murphy
  • Influenza hemagglutinin and neuraminidase variants
    Patent number: 7504109
    Abstract: Polypeptides, polynucleotides, methods, compositions, and vaccines comprising (avian pandemic) influenza hemagglutinin and neuraminidase variants are provided.
    Type: Grant
    Filed: May 20, 2005
    Date of Patent: March 17, 2009
    Assignees: MedImmune, LLC, The United States of America as Represented by The Department of Health Services, National Institute of Health
    Inventors: Chin-Fen Yang, George Kemble, Kanta Subbarao, Brian Murphy
  • Influenza Hemagglutinin And Neuraminidase Variants
    Publication number: 20080069821
    Abstract: Polypeptides, polynucleotides, methods, compositions, and vaccines comprising (avian pandemic) influenza hemagglutinin and neuraminidase variants are provided.
    Type: Application
    Filed: August 9, 2007
    Publication date: March 20, 2008
    Applicants: MedImmune Vaccines, Inc., The Government of the United States of America National Institutes of Health
    Inventors: Chin-Fen Yang, George Kemble, Kanta Subbarao, Brian Murphy
  • Purified trimeric S protein as vaccine against severe acute respiratory syndrome virus infections
    Publication number: 20070003577
    Abstract: Immunogenic compositions and vaccines associated with the Spike protein of SARS Corona Virus (SARS CoV) are disclosed.
    Type: Application
    Filed: June 27, 2006
    Publication date: January 4, 2007
    Inventors: Yiu Kam, Francois Kien, Kid Chu, Anjeanette Roberts, Kanta Subbarao
  • Influenza hemagglutinin and neuraminidase variants
    Publication number: 20060008473
    Abstract: Polypeptides, polynucleotides, methods, compositions, and vaccines comprising (avian pandemic) influenza hemagglutinin and neuraminidase variants are provided.
    Type: Application
    Filed: May 20, 2005
    Publication date: January 12, 2006
    Inventors: Chin-Fen Yang, George Kemble, Kanta Subbarao, Brian Murphy